ANGUS Chemical Company, a global manufacturer and marketer of specialty ingredients and consumables for biotechnology, pharmaceutical, consumer and industrial applications, has announced the appointment of Jonathan Arnold to the Company’s Board of Directors.
“Throughout his extensive career, Jonathan has demonstrated an ability to build, develop and lead strong teams that are aligned to successfully deliver on strategic operational and growth objectives,” said David Neuberger, ANGUS President and Chief Executive Officer. “We look forward to the deep commercial and operations expertise Jonathan brings to our expanded board as we continue to enhance our capabilities for serving the global life sciences and pharmaceutical markets.”
“Via investments in capacity, people and products, ANGUS is continuously demonstrating its commitment to become a leading global supplier of essential life sciences ingredients,” said Arnold. “I am excited to join the board and look forward to contributing to ANGUS’ future success and strategic transformation.”
Arnold currently serves as President, Oral and Special Delivery, for Catalent Pharma Solutions. In this role, he has direct responsibility for 10 sites and approximately 2,400 employees covering three core technology segments. He previously served as Vice President and General Manager of the company’s Drug Delivery Solutions business unit.
Prior to Catalent, Arnold most recently held the role of Chief Procurement Officer and Vice President of Global Supply Chain at Patheon, a global life sciences CDMO.
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.